Follow
John D. Anderson
Title
Cited by
Cited by
Year
Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis
JD Anderson, KH Bagamian, F Muhib, MP Amaya, LA Laytner, T Wierzba, ...
The Lancet Global Health 7 (3), e321-e330, 2019
1062019
Strengthening the argument for rapid brain MR imaging: estimation of reduction in lifetime attributable risk of developing fatal cancer in children with shunted hydrocephalus …
K Koral, T Blackburn, AA Bailey, KM Koral, J Anderson
American journal of neuroradiology 33 (10), 1851-1854, 2012
782012
Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness
R Rheingans, D Atherly, J Anderson
Vaccine 30, A15-A23, 2012
692012
The association between domestic animal presence and ownership and household drinking water contamination among peri-urban communities of Kisumu, Kenya
AN Barnes, JD Anderson, J Mumma, ZH Mahmud, O Cumming
PloS one 13 (6), e0197587, 2018
522018
Measuring disparities in sanitation access: does the measure matter?
R Rheingans, JD Anderson, R Luyendijk, O Cumming
Tropical Medicine & International Health 19 (1), 2-13, 2014
462014
Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low-and lower middle-income countries
JD Anderson IV, KH Bagamian, F Muhib, R Baral, LA Laytner, M Amaya, ...
Vaccine: X 2, 100024, 2019
362019
Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk …
KH Bagamian, JD Anderson, F Muhib, O Cumming, LA Laytner, ...
The Lancet Global Health 8 (1), e101-e112, 2020
322020
Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities
R Rheingans, JD Anderson IV, B Anderson, P Chakraborty, D Atherly, ...
Vaccine 32, A140-A150, 2014
302014
Estimating inequities in sanitation-related disease burden and estimating the potential impacts of pro-poor targeting
R Rheingans, O Cumming, J Anderson, J Showalter
London: SHARE: Sanitation and Hygiene Applied Research for Equity, 2012
292012
Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan
R Rheingans, JD Anderson IV, KH Bagamian, LA Laytner, CJ Pecenka, ...
Vaccine 36 (51), 7780-7789, 2018
222018
High-resolution spatial distribution and estimation of access to improved sanitation in Kenya
P Jia, JD Anderson, M Leitner, R Rheingans
PLoS One 11 (7), e0158490, 2016
222016
Systematic review of the economic value of diarrheal vaccines
R Rheingans, M Amaya, J Anderson, P Chakraborty, J Atem
Human vaccines & immunotherapeutics 10 (6), 1582-1594, 2014
222014
The safe start trial to assess the effect of an infant hygiene intervention on enteric infections and diarrhoea in low-income informal neighbourhoods of Kisumu, Kenya: a study …
J Mumma, S Simiyu, E Aseyo, J Anderson, A Czerniewska, E Allen, ...
BMC infectious diseases 19, 1-11, 2019
192019
Interlocking Inequalities Related to Water and Sanitation, Nutrition and Healthcare Access
O Cumming, J Anderson
Equality in Water and Sanitation Services, 212-231, 2018
16*2018
Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People’s Democratic Republic
R Rheingans, JD Anderson IV, KH Bagamian, CJ Pecenka
Vaccine 36 (51), 7868-7877, 2018
142018
Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria
JD Anderson IV, CJ Pecenka, KH Bagamian, RD Rheingans
PLoS One 15 (5), e0232941, 2020
112020
Environmental and behavioural exposure pathways associated with diarrhoea and enteric pathogen detection in 5-month-old, periurban Kenyan infants: a cross-sectional study
KK Baker, JAO Mumma, S Simiyu, D Sewell, K Tsai, JD Anderson, ...
BMJ open 12 (10), e059878, 2022
102022
Heterogeneity in potential impact and cost-effectiveness of ETEC and Shigella vaccination in four sub-Saharan African countries
JD Anderson IV, F Muhib, R Rheingans, T Wierzba
Vaccine: X 3, 100043, 2019
102019
Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study
JD Anderson, KH Bagamian, CJ Pecenka, F Muhib, CA Puett, ...
The Lancet Global Health 11 (6), e880-e891, 2023
92023
Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study
C Puett, JD Anderson, KH Bagamian, F Muhib, S Scheele, WP Hausdorff, ...
The Lancet Global Health 11 (6), e892-e902, 2023
72023
The system can't perform the operation now. Try again later.
Articles 1–20